FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells

In order to exploit the specific vulnerabilities of tumors, it is urgent to identify the basis of associated defects in genome maintenance. One unsolved problem is the mechanism of inhibition of processing of DNA double-strand break repair by REV7 and its influence on DNA repair pathways. We searched for REV7-associated proteins in human cells and found FAM35A, a protein of previously unknown function. By analyzing the FAM35A sequence we discovered that FAM35A has an unstructured N-terminal region and a C-terminal region harboring three OB-fold domains similar to single-stranded binding protein RPA. Knockdown of FAM35A caused sensitivity to DNA damaging agents, and FAM35A re-localized in damaged cell nuclei. In a BRCA1 mutant cell line, however, depletion of FAM35A increased resistance to camptothecin, suggesting that FAM35A participates in processing of DNA ends to allow more efficient DNA repair. Moreover, we found FAM35A absent in one widely used BRCA1-mutant cancer cell line (HCC1937) with anomalous resistance to PARP inhibitors. A survey of FAM35A alterations in cancer revealed that the gene is altered at the highest frequency in prostate cancers (up to 13%) and significantly less expressed in metastatic cases. The results reveal a new DNA repair factor with promise as a therapeutically relevant cancer marker.

[1]  R. Wood,et al.  FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1‐defective cells , 2018, bioRxiv.

[2]  David W. Wyatt.  Essential Roles for Polymerase Theta-Mediated End Joining in Repair of Chromosome Breaks , 2017 .

[3]  Joonyoung Her,et al.  BLM helicase regulates DNA repair by counteracting RAD51 loading at DNA double-strand break sites , 2017, The Journal of cell biology.

[4]  Y. Ishikawa,et al.  Dynamic feature of mitotic arrest deficient 2-like protein 2 (MAD2L2) and structural basis for its interaction with chromosome alignment-maintaining phosphoprotein (CAMP). , 2017, The Journal of biological chemistry.

[5]  David W. Wyatt,et al.  Essential Roles for Polymerase θ-Mediated End Joining in the Repair of Chromosome Breaks. , 2016, Molecular cell.

[6]  Robert A. Baldock,et al.  Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection , 2016, Nature Structural &Molecular Biology.

[7]  S. Cantor,et al.  Replication Fork Stability Confers Chemoresistance in BRCA-deficient Cells , 2016, Nature.

[8]  Michael J E Sternberg,et al.  The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.

[9]  D. Durocher,et al.  MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5′ end-resection , 2015, Nature.

[10]  Peter Bouwman,et al.  REV7 counteracts DNA double-strand break resection and affects PARP inhibition , 2015, Nature.

[11]  Kyle M. Miller,et al.  Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination , 2015, Nature.

[12]  R. Wood,et al.  REV7 is essential for DNA damage tolerance via two REV3L binding sites in mammalian DNA polymerase ζ , 2015, Nucleic acids research.

[13]  D. Livingston,et al.  BRCA1 Pathway Function in Basal-Like Breast Cancer Cells , 2014, Molecular and Cellular Biology.

[14]  David J. Chen,et al.  The Transcription Factor TFII-I Promotes DNA Translesion Synthesis and Genomic Stability , 2014, PLoS genetics.

[15]  M. Gregory,et al.  Human Pol ζ purified with accessory subunits is active in translesion DNA synthesis and complements Pol η in cisplatin bypass , 2014, Proceedings of the National Academy of Sciences.

[16]  J. Sale,et al.  Sequestration of CDH1 by MAD2L2 prevents premature APC/C activation prior to anaphase onset , 2013, The Journal of cell biology.

[17]  Richard D. Wood,et al.  Human DNA helicase HELQ participates in DNA interstrand crosslink tolerance with ATR and RAD51 paralogs , 2013, Nature Communications.

[18]  M. Kessel,et al.  A Critical Function of Mad2l2 in Primordial Germ Cell Development of Mice , 2013, PLoS genetics.

[19]  D. Durocher,et al.  53BP1 is a reader of the DNA damage-induced H2A Lys15 ubiquitin mark , 2013, Nature.

[20]  Tomonari Matsuda,et al.  A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair , 2013, Nucleic acids research.

[21]  L. O’Driscoll,et al.  Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines , 2013, Cancer Biology & Therapy.

[22]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[23]  Adam P. Rosebrock,et al.  A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. , 2013, Molecular cell.

[24]  Y. Murakumo,et al.  The REV7 Subunit of DNA Polymerase ζ Is Essential for Primordial Germ Cell Maintenance in the Mouse* , 2013, The Journal of Biological Chemistry.

[25]  N. Pavletich,et al.  Structure and conformational change of a replication protein A heterotrimer bound to ssDNA. , 2012, Genes & development.

[26]  S. Jackson,et al.  RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. , 2012, Genes & development.

[27]  Benjamin J. Raphael,et al.  The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer , 2016 .

[28]  Edward L. Huttlin,et al.  Systematic and quantitative assessment of the ubiquitin-modified proteome. , 2011, Molecular cell.

[29]  X. Chen,et al.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. , 2011, The Journal of clinical investigation.

[30]  Y. Drew,et al.  Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2. , 2011, Journal of the National Cancer Institute.

[31]  A. Yasui,et al.  CAMP (C13orf8, ZNF828) is a novel regulator of kinetochore–microtubule attachment , 2011, The EMBO journal.

[32]  A. Hyman,et al.  Quantitative Interaction Proteomics and Genome-wide Profiling of Epigenetic Histone Marks and Their Readers , 2010, Cell.

[33]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[34]  Jeremy M. Stark,et al.  53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks , 2010, Cell.

[35]  Y. Murakumo,et al.  Crystal Structure of Human REV7 in Complex with a Human REV3 Fragment and Structural Implication of the Interaction between DNA Polymerase ζ and REV1* , 2010, The Journal of Biological Chemistry.

[36]  L. Hetterschijt,et al.  The Mitotic Arrest Deficient Protein MAD2B Interacts with the Small GTPase RAN throughout the Cell Cycle , 2009, PloS one.

[37]  Paolo Romano,et al.  Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines , 2008, Nucleic Acids Res..

[38]  H. Kimura,et al.  DNA Damage-Dependent Acetylation and Ubiquitination of H2AX Enhances Chromatin Dynamics , 2007, Molecular and Cellular Biology.

[39]  B. A. Ballif,et al.  ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage , 2007, Science.

[40]  Roland Eils,et al.  Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes , 2007, BMC Cancer.

[41]  T. Barrette,et al.  Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. , 2007, Neoplasia.

[42]  John T. Wei,et al.  Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. , 2005, Cancer cell.

[43]  David J. Chen,et al.  MDC1 Regulates DNA-PK Autophosphorylation in Response to DNA Damage* , 2004, Journal of Biological Chemistry.

[44]  R. Tibshirani,et al.  Gene expression profiling identifies clinically relevant subtypes of prostate cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Zhihui Feng,et al.  Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair , 2004, Molecular and Cellular Biology.

[46]  W. Chazin,et al.  Independent and Coordinated Functions of Replication Protein A Tandem High Affinity Single-stranded DNA Binding Domains* , 2003, Journal of Biological Chemistry.

[47]  J. Cheville,et al.  Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. , 2003, Cancer research.

[48]  E. Bochkareva,et al.  Structure of the RPA trimerization core and its role in the multistep DNA‐binding mechanism of RPA , 2002, The EMBO journal.

[49]  Y. L. Lin,et al.  The Evolutionarily Conserved Zinc Finger Motif in the Largest Subunit of Human Replication Protein A Is Required for DNA Replication and Mismatch Repair but Not for Nucleotide Excision Repair* , 1998, The Journal of Biological Chemistry.

[50]  V. Ogryzko,et al.  Immunoaffinity purification of mammalian protein complexes. , 2003, Methods in enzymology.